Kawain Inhibits Urinary Bladder Carcinogenesis through Epigenetic Inhibition of LSD1 and Upregulation of H3K4 Methylation. 2023

Xia Xu, and Xuejiao Tian, and Liankun Song, and Jun Xie, and Joseph C Liao, and Joshua J Meeks, and Xue-Ru Wu, and Greg E Gin, and Beverly Wang, and Edward Uchio, and Xiaolin Zi
Department of Urology, University of California, Irvine, Orange, CA 92868, USA.

Epidemiological evidence suggests that kava (Piper methysticum Forst) drinks may reduce the risk of cancer in South Pacific Island smokers. However, little is known about the anti-carcinogenic effects of kava on tobacco smoking-related bladder cancer and its underlying mechanisms. Here we show that dietary feeding of kawain (a major active component in kava root extracts) to mice either before or after hydroxy butyl(butyl) nitrosamine (OH-BBN) carcinogen exposure slows down urinary bladder carcinogenesis and prolongs the survival of the OH-BBN-exposed mice. OH-BBN-induced bladder tumors exhibit significantly increased expression of lysine-specific demethylase 1 (LSD1), accompanied by decreased levels of H3K4 mono-methylation compared to normal bladder epithelium, whereas dietary kawain reverses the effects of OH-BBN on H3K4 mono-methylation. Human bladder cancer tumor tissues at different pathological grades also show significantly increased expression of LSD1 and decreased levels of H3K4 mono-methylation compared to normal urothelium. In addition, kava root extracts and the kavalactones kawain and methysticin all increase the levels of H3K4 mono- and di-methylation, leading to inhibitory effects on cell migration. Taken together, our results suggest that modification of histone lysine methylation may represent a new approach to bladder cancer prevention and treatment and that kavalactones may be promising agents for bladder cancer interception in both current and former smokers.

UI MeSH Term Description Entries
D008239 Lysine An essential amino acid. It is often added to animal feed. Enisyl,L-Lysine,Lysine Acetate,Lysine Hydrochloride,Acetate, Lysine,L Lysine
D001743 Urinary Bladder A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION. Bladder,Bladder Detrusor Muscle,Detrusor Urinae,Bladder Detrusor Muscles,Bladder, Urinary,Detrusor Muscle, Bladder,Detrusor Muscles, Bladder
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D044127 Epigenesis, Genetic A genetic process by which the adult organism is realized via mechanisms that lead to the restriction in the possible fates of cells, eventually leading to their differentiated state. Mechanisms involved cause heritable changes to cells without changes to DNA sequence such as DNA METHYLATION; HISTONE modification; DNA REPLICATION TIMING; NUCLEOSOME positioning; and heterochromatization which result in selective gene expression or repression. Epigenetic Processes,Epigenetic Process,Epigenetics Processes,Genetic Epigenesis,Process, Epigenetic,Processes, Epigenetic,Processes, Epigenetics
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D056466 Histone Demethylases Enzymes that catalyse the removal of methyl groups from LYSINE or ARGININE residues found on HISTONES. Many histone demethylases generally function through an oxidoreductive mechanism. Histone Demethylase,Histone Lysine Demethylase,Histone Arginine Demethylases,Histone Lysine Demethylases,Arginine Demethylases, Histone,Demethylase, Histone,Demethylase, Histone Lysine,Demethylases, Histone,Demethylases, Histone Arginine,Demethylases, Histone Lysine,Lysine Demethylase, Histone,Lysine Demethylases, Histone
D063646 Carcinogenesis The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years. Tumorigenesis,Oncogenesis,Carcinogeneses,Oncogeneses,Tumorigeneses

Related Publications

Xia Xu, and Xuejiao Tian, and Liankun Song, and Jun Xie, and Joseph C Liao, and Joshua J Meeks, and Xue-Ru Wu, and Greg E Gin, and Beverly Wang, and Edward Uchio, and Xiaolin Zi
June 2016, Stem cell reviews and reports,
Xia Xu, and Xuejiao Tian, and Liankun Song, and Jun Xie, and Joseph C Liao, and Joshua J Meeks, and Xue-Ru Wu, and Greg E Gin, and Beverly Wang, and Edward Uchio, and Xiaolin Zi
January 2014, Molecular & cellular oncology,
Xia Xu, and Xuejiao Tian, and Liankun Song, and Jun Xie, and Joseph C Liao, and Joshua J Meeks, and Xue-Ru Wu, and Greg E Gin, and Beverly Wang, and Edward Uchio, and Xiaolin Zi
March 2008, Cancer research,
Xia Xu, and Xuejiao Tian, and Liankun Song, and Jun Xie, and Joseph C Liao, and Joshua J Meeks, and Xue-Ru Wu, and Greg E Gin, and Beverly Wang, and Edward Uchio, and Xiaolin Zi
August 2011, The EMBO journal,
Xia Xu, and Xuejiao Tian, and Liankun Song, and Jun Xie, and Joseph C Liao, and Joshua J Meeks, and Xue-Ru Wu, and Greg E Gin, and Beverly Wang, and Edward Uchio, and Xiaolin Zi
January 2001, Developments in biologicals,
Xia Xu, and Xuejiao Tian, and Liankun Song, and Jun Xie, and Joseph C Liao, and Joshua J Meeks, and Xue-Ru Wu, and Greg E Gin, and Beverly Wang, and Edward Uchio, and Xiaolin Zi
October 1983, European journal of cancer & clinical oncology,
Xia Xu, and Xuejiao Tian, and Liankun Song, and Jun Xie, and Joseph C Liao, and Joshua J Meeks, and Xue-Ru Wu, and Greg E Gin, and Beverly Wang, and Edward Uchio, and Xiaolin Zi
January 1998, Toxicologic pathology,
Xia Xu, and Xuejiao Tian, and Liankun Song, and Jun Xie, and Joseph C Liao, and Joshua J Meeks, and Xue-Ru Wu, and Greg E Gin, and Beverly Wang, and Edward Uchio, and Xiaolin Zi
January 1984, IARC scientific publications,
Xia Xu, and Xuejiao Tian, and Liankun Song, and Jun Xie, and Joseph C Liao, and Joshua J Meeks, and Xue-Ru Wu, and Greg E Gin, and Beverly Wang, and Edward Uchio, and Xiaolin Zi
January 1982, Pathobiology annual,
Xia Xu, and Xuejiao Tian, and Liankun Song, and Jun Xie, and Joseph C Liao, and Joshua J Meeks, and Xue-Ru Wu, and Greg E Gin, and Beverly Wang, and Edward Uchio, and Xiaolin Zi
April 2007, Molecular cell,
Copied contents to your clipboard!